Common Shares Outstanding: The number of class A shares currently held by investors.
SpyGlass Pharma, Inc. (SGP) had Common Shares Outstanding of 33.46M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-24.25M |
|
-- |
|
-- |
|
$26.25M |
|
$-26.25M |
|
$1.99M |
|
$-24.25M |
|
$-24.25M |
|
$-24.25M |
|
$-24.25M |
|
$-24.25M |
|
$-24.25M |
|
$-26.25M |
|
$-25.96M |
|
33.45M |
|
33.45M |
|
$-0.73 |
|
$-0.73 |
|
| Balance Sheet Financials | |
$217.91M |
|
$6.34M |
|
$8.43M |
|
$226.35M |
|
$14.30M |
|
-- |
|
$1.61M |
|
$15.91M |
|
$210.44M |
|
$210.44M |
|
$210.44M |
|
|
Common Shares Outstanding |
33.46M |
| Cash Flow Statement Financials | |
$-44.40M |
|
$-1.06M |
|
$157.79M |
|
$96.36M |
|
$208.69M |
|
$112.33M |
|
$6.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-49.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.52% |
|
-11.52% |
|
-10.71% |
|
-11.52% |
|
$6.29 |
|
$-1.48 |
|
$-1.33 |
|